The major histocompatibility complex (MHC) class l-related receptor FcRn is involved in regulating serum gammaglobulin (IgG) levels in mice. With the aim of increasing the serum half-life of a recombinant murine Fcγ1 fragment, the affinity for binding to FcRn at pH 6,0 has been increased by random mutagenesis of Thr252, Thr254, and Thr256 followed by selection using bacteriophage display. These residues were chosen as they are in proximity to the FcRn-IgG (Fc) interaction site. Two mutants with higher affinity (due to lower off-rates) than the wild-type Fc have been isolated and analyzed in pharmacokinetic studies in mice. The mutant with the highest affinity has a significantly longer serum half-life than the wild type fragment, despite its lower off-rate from FcRn at pH 7.4. The results provide support for the involvement of FcRn in the home-ostasis of serum IgGs in mice. The indications that a homologous FcRn regulates IgG levels in humans suggest that this approach has implications for increasing the serum persistence of therapeutic antibodies.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Ghetie, V., Hubbard, J. G., Kim, J.K., Tsen, M.F., Lee, Y., and Ward, E.S., 1966. Abnormally short serum half-lives of IgG in β2-microglobulin deficient mice. Eur. J. Immunol. 26: 690–696.
Junghans, R.P. and Anderson, C.L. 1966. The protection receptor for IgG catabolism is the 32-microglobulin-containing neonatal intestinal transport receptor. Proc. Natl. Acad. Sci. USA 93: 5512–5516.
Israel, E.J., Wilsker, D.F., Hayes, K.C., Schoenfeld, D. and Simister, N.E., 1996. Increased clearance of IgG in mice that lack β2-microglobulin: possible protective role for FcRn Immunol. 89: 573–578.
Wallace, K.H. and Rees, A.R., 1980. Studies on the Immunoglobulin-G Fc fragment receptor from neonatal rat small intestine. Biochem.J. 188: 9–16.
Rodewald, R. and Kraehenbuhl, J.P, 1984. Receptor-mediated transport of IgG. J. CellBiol 99: 154s–164s.
Roberts, D.M. Guenthert, M. and Rodewald, RJ. 1966. Isolation and characterisation of the Fc receptor from the fetal yolk sac of the rat J. Cell Biol. 111: 1867–1876.
Israel, E.J., Patel, V.K. Taylor, S.F., Marshak-Rothstein, A. and Simister, N.E., 1995. Requirement for a β2-microglobulin associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J. Immunol. 154: 6246–6251.
Kristoffersen, E.K. and Simister, N.E., 1995. Co-localisation of the neonatal Fc-y receptor and IgG in human placental term syncytiotrophoblast. Eur. J. Immunol. 26: 1668–1671.
Simister, N.E. Story, C.M. Chen, H-L and Hunt, J.S. 1996. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur. J. Immunol. 26: 1527–1531.
Leach, J.L, Sedmark, D.D., Osborne, J.M., Rahill, B., Lairmore, M.D. and Anderson, C.L. 1966. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast J. Immunol. 157: 3317–3322.
Kirn, K., Tsen, M.F., Ghetie, V. and Ward, E.S., 1994. Localization of the site of the murine lgG1 molecule that is involved in binding to the murine intestinal Fc receptor. Eur. J. Immunol. 24: 2429–2434.
Medesan, C, Radu, C, Kim, J.K., Ghetie, V,and Ward, E.S., 1997. Localization of the site of the IgG molecule that regulates matemofetal transmission in mice Eur. J. Immunol. 26: 2533–2536.
Medesan, C., Matesoi, D, Radu, C, Ghetie, V and Ward, E.S., 1997. Delineation of the amino acid residues involved in transcytosis and catabolism of mouse lgG1 J. Immunol. 158: 2211–2217.
Edelman, G.M., Cunningham, B.A., Gall, W.E. GottHeb, R.D., Rutishauser, U. and Waxdal, M.J. 1969. TriecovalentstmctureafaneγG Molecule. Proc. Natl. Acad. Sci. USA. 63: 78–85.
Deisenhofer, J. 1981. Crystallographic refinement and atomic models of human Fc fragment and its complex from fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 A resolution. Biochemistry. 20: 2361–2370.
Burmeister, W.P., Huber, A.H. and Bjorkman, P.J. 1994. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature. 372: 379–383.
Raghavan, M., Bonagura, V.R., Morrison, S.L. and Bjorkman, P.J. 1995. Analysis of the pH dependence of the neonatal receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry. 34: 14649–14657.
Popov, S, Hubbard, J. G., Kim, J.K., Ober, B., Ghetie, V. and Ward, E.S., 1966. The stoichiometry and affinity of interaction of murine Fc fragments with the MHC class l-related receptor, FcRn. Mol. Immunol. 33: 521–530.
Kabat, E.A., Wu, T.T., Perry, H.M., Gottesman, K.S. and Foeller, C 1991. Sequences of proteins of immunological interest. US Department of Health and Human Services.
Story, C.M., Mikulska, J.E. and Simister, N.E. 1994. A major histocompatibility complex class l-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J. Exp. Med. 180: 2377–2381.
Kim, U.K., Tsen, M-F, Ghetie, V. and Ward, E.S., 1994. Identifying amino acid residues that influence plasma clearance of mouse lgG1 fragments by site directed mutagenesis. Eur. J. Immunol. 24: 542–548.
Hoogenboom, H.R., Griffiths, A.D., Johnson, K.S., Chiswell, D.J., Hudson, P and Winter, G 1991. Multisubunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucl. Acids Res. 19: 4133–4137.
Zijlstra, M., Bix, M Simister, M.E., Loring, J.M., Raulet, D.H. and Jaenisch, R 1990. β2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature. 344: 742–746.
Brambell, F.W.R., Hemmings, W.A. and Morris, I.G. 1964. A theoretical model of gammaglobulin catabolism. Nature. 203: 1352–1355.
Duncan, A.R. Woof, J.M. Partridge, L.J. Burton, D.R. and Winter, G 1988. Localization of the binding site for the human high affinity Fc receptor on IgG. Nature. 332: 563–564.
Sarmay, G., Lund, J., Rozsnyay, Z., Gergely, J. and Jefferis, R. 1992. Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc receptor. Mol. Immunol. 29: 633–639.
Duncan, A.R. and Winter, G. 1988. The binding site for C1 q on IgG. Nature. 332: 738–740.
Horton, R.M., Hunt, H.D., Ho, S.N., Pulten, J.K. and Pease, L.R. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 77: 61–68.
Marks, J.D., Hoogenboom, H.R., Bonnett, T.R., McCafferty, J., Griffiths, A.D. and Winter, G. 1991. By-passing immunisation: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222: 581–597.
Ward, E.S. 1994. VH shuffling can be used to convert an Fv fragment of anti-hen egg lysozyme specificity to one that recognizes a T cell receptor Va. Mol. Immunol. 32: 147–156.
Ames, G.F., Prody, C. and Kustu, S. 1980. Simple, rapid and quantitative release of periplasmic proteins by chloroform. J. Bacteriol. 160: 1181–1183.
Ward, E.S., Guessow, D., Griffiths, A.D., Jones, P.T. and Winter, G. 1989. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature. 341: 544–546.
Ward, E.S. 1992. Secretion of soluble T cell receptor fragments from recombinant Escherichia coli cells J. Mol. Biol. 224: 885–890.
About this article
Cite this article
Ghetie, V., Popov, S., Borvak, J. et al. Increasing the serum persistence of an IgG fragment by random mutagenesis. Nat Biotechnol 15, 637–640 (1997). https://doi.org/10.1038/nbt0797-637
Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo
International Journal of Molecular Sciences (2021)
Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review
European Journal of Pharmaceutical Sciences (2020)
Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment